Select date

April 2024
Mon Tue Wed Thu Fri Sat Sun

America’s Infant Mortality Rate Increases for the First Time in 20 Years

16-4-2024 < SGT Report 10 1032 words
 

More infants are now dying in the U.S. than in the last two decades, according to data from the National Center for Health Statistics (NCHS).1 The U.S. provisional infant mortality rate rose 3% from 2021 to 2022 — the first increase since 2001 to 2002. Prior to this increase, infant mortality rates had declined 22% between 2002 and 2021.


“Seeing an increase that hits the statistical significance mark indicates that this was a bigger jump than we’ve had in the last 20 years, and that is something we need to keep an eye on to see if it’s just a one-year anomaly or the start of increasing rates,” study author Danielle M. Ely, an NCHS health statistician, told The New York Times.2


The rise in infant mortality comes alongside other concerning health care news, including a drop in life expectancy, signaling deeper problems with the state of U.S. medical care.3 Fortunately, there are many steps you can take to stay healthy at all life stages.


US Infant Mortality on the Rise


Infant mortality in the U.S. rose from 5.44 per 1,000 live births in 2021 to 5.6 in 2022. Overall, this represents 20,538 deaths in infants under 12 months in 2022, up from 19,928 the year prior.4 From 2021 to 2022, there were notable increases in mortality rates across several categories in particular:5



  • Neonatal and postneonatal infant deaths — Neonatal deaths, which are those that occur before the 28th day of life, rose 3%, while postneonatal deaths, those that occur between 28 and 364 days of life, rose 4%.

  • Infants born to American Indian, Alaska Native and white women — Mortality rates increased significantly from 7.46 deaths per 1,000 live births to 9.06 among infants of American Indian and Alaska Native women, as well as from 4.36 to 4.52 among white women.

  • Infants born to women ages 25 to 29 — Infant mortality rates increased significantly in this group, from 5.15 deaths per 1,000 live births to 5.37.

  • Male infants — Deaths among male infants rose from 5.83 infant deaths per 1,000 live births to 6.06.

  • Infants in four states — Infant mortality rates increased in Georgia, Iowa, Missouri and Texas.



Among the leading causes of death, infant mortality rates increased in cases of maternal complications and bacterial sepsis, according to the report.6 “Maternal complications may reflect the worsening state of care for pregnant women, about 6 million of whom live in areas devoid of maternal care. Also, pregnant women have increasing rates of obesity, diabetes, hypertension, and other conditions,” medical and science writer Janice Hopkins Tanne wrote in the BMJ.7


In 2022, more than one-third of the 3,143 counties in the U.S were classified as maternity “deserts” without hospitals or birth centers offering obstetric care, and with no obstetric providers. The lack of care was blamed on finances, as obstetric care services are “deemed unprofitable.”8



Were the COVID-19 Pandemic — and COVID Jabs — Involved?


The rise in infant mortality in 2022 could have links to the pandemic, since most babies born that year were conceived in 2021 during the COVID-19 pandemic — and the year that COVID-19 shots were widely rolled out. Maternal deaths rose by 40% during the pandemic9 and increases in stillbirths were reported.10


By November 12, 2021, there were 2,620 cases of fetal death or stillbirth among women who received a COVID-19 injection reported to the Vaccine Adverse Event Reporting System (VAERS).11 Health Impact News ran the same VAERS search but excluded COVID-19 injections — so looking for fetal deaths in women who had been vaccinated with any vaccine other than a COVID-19 jab over the last 30+ years. They found:12


“We are currently on pace to see a yearly total of 2,838 recorded fetal deaths following COVID-19 shots, while the yearly average of recorded fetal deaths following the vaccination of pregnant women for the past 30 years has been an average of 74 fetal deaths per year.”


Problems began to appear shortly after COVID-19 shots were rolled out, such that a leaked email from a large California hospital was sent out in warning to 200 nurses. The email, from September 2022, contained the subject line, “Demise Handling,” referring to an increase in stillbirths and fetal deaths. A TCW report by journalist Sally Beck shared the email’s content, which read:13


“It seems as though the increase of demise patients [babies] that we are seeing is going to continue. There were 22 demises [stillbirths and fetal deaths] in August [2022], which ties [equals] the record number of demises in July 2021, and so far in September [2022] there have been 7 and it’s only the 8th day of the month.”


Beck reports that one nurse, Michelle Gershman, who works in the neonatal ward had her bonus withheld because she spoke out about the rise in fetal deaths. “We used to have one fetal demise per month. That rose to one or two per week,” Gershman said. Beck reported:14


“Her experience, and the experience of doctors working with pregnant women, is contrary to official ‘safe and effective’ observation and advice, but no one was free to speak out because of a gagging order imposed in September 202115 by the American Board of Obstetrics and Gynecology (ACOG).


… At the beginning of the rollout, in December 2020, pregnant women who were healthcare workers or deemed to be at risk from Covid began receiving the shots.


By May 2021, the vaccine was being recommended to all pregnant American women, despite the fact that none of the vaccine manufacturers had completed reproductive toxicology reports in animals, and none had started clinical trials in pregnant women. Two months later, hospitals noticed a huge increase in miscarriage, stillbirth, preterm births, pregnancy complications and menstrual abnormalities.”


Board-certified internist and cardiologist Dr. Peter McCullough stated COVID-19 shots should be given the Category X designation during pregnancy,16 which means, “The risk of use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.”17


Print